Patents by Inventor Tina deVries

Tina deVries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240033250
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Application
    Filed: June 8, 2023
    Publication date: February 1, 2024
    Applicant: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Publication number: 20230355587
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Application
    Filed: December 23, 2022
    Publication date: November 9, 2023
    Inventors: Tina DEVRIES, David JACOBS
  • Patent number: 11701343
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: May 9, 2022
    Date of Patent: July 18, 2023
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Patent number: 11541036
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: January 3, 2023
    Assignee: RVL PHARMACEUTICALS, INC.
    Inventors: Tina Devries, David Jacobs
  • Publication number: 20220273621
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Application
    Filed: May 9, 2022
    Publication date: September 1, 2022
    Inventors: Tina deVries, David Jacobs
  • Publication number: 20220257566
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Application
    Filed: April 25, 2022
    Publication date: August 18, 2022
    Inventors: Tina DEVRIES, David JACOBS
  • Patent number: 11324722
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: May 10, 2022
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Patent number: 11311515
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: April 26, 2022
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina Devries, David Jacobs
  • Patent number: 11219615
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: January 11, 2022
    Assignee: RVL PHARMACEUTICALS, INC.
    Inventors: Tina deVries, David Jacobs
  • Publication number: 20210386711
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Application
    Filed: August 30, 2021
    Publication date: December 16, 2021
    Inventors: Tina DEVRIES, David JACOBS
  • Patent number: 11103482
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: August 31, 2021
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Publication number: 20210212992
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Application
    Filed: March 8, 2021
    Publication date: July 15, 2021
    Inventors: Tina deVries, David Jacobs
  • Publication number: 20210137889
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Application
    Filed: January 21, 2021
    Publication date: May 13, 2021
    Inventors: Tina deVries, David Jacobs
  • Patent number: 10940138
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: March 9, 2021
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Publication number: 20210023222
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Application
    Filed: October 7, 2020
    Publication date: January 28, 2021
    Inventors: Tina deVries, David Jacobs
  • Patent number: 10898573
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: January 26, 2021
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Publication number: 20210015795
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Application
    Filed: October 5, 2020
    Publication date: January 21, 2021
    Inventors: Tina deVries, David Jacobs
  • Publication number: 20200353083
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Application
    Filed: December 16, 2019
    Publication date: November 12, 2020
    Inventors: Tina deVries, David Jacobs
  • Patent number: 10814001
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: October 27, 2020
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Patent number: 10799481
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: October 13, 2020
    Assignee: RVL PHARMACEUTICALS, INC.
    Inventors: Tina deVries, David Jacobs